PhD scholarship recipients

The Leukaemia Foundation and HSANZ are helping more medical and science graduates pursue a research career in blood cancer by co-funding PhD scholarships.

T-cell versus T-cell biology: mechanisms and modulation of disease and therapy

Treatment of acute myeloid leukaemia at the timepoint when small amounts of leukaemia cells are detected to prevent advanced disease

Improving outcomes for patients after donated stem cell transplants

DR RAY KOO: Improving outcomes for patients after donated stem cell transplants

Clonal haematopoiesis of indeterminate potential (CHIP) – what does it mean?

DR JASMINE SINGH: Investigating the effect of aspirin on genetic risk factors for blood cancer

Investigating mechanisms of disease development and new therapies in AML with high-risk genetic alternations

Targeting the cancer-immune crosstalk in AML

Identifying subclones in early phase MPN that drive progression and leukaemic transformation

Investigating the gene mutations and biological pathways that lead to the development of MPNs

Development of improved biomarkers and targeted therapies for MPN

Evaluating the evidence base, current practice and clinical outcomes of immunoglobulin treatment

Using antifungal treatments to prevent infection in people with blood cancers and those undergoing bone marrow transplants